Expression of YTHDF1, YTHDF2, YTHDC1, and METTL3 in the low-risk group was significantly high compared with the high-risk group, which suggests that m6A modification may affect the progression of BC (Supplementary Figure S6A). Here, METTL3 is linked to breast cancer.